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Abstract
We conducted a joint (pooled) analysis of three genome-wide association studies (GWAS) 1-3 of 
esophageal squamous cell carcinoma (ESCC) in ethnic Chinese (5,337 ESCC cases and 5,787 
controls) with 9,654 ESCC cases and 10,058 controls for follow-up. In a logistic regression model 
adjusted for age, sex, study, and two eigenvectors, two new loci achieved genome-wide 
significance, marked by rs7447927 at 5q31.2 (per-allele odds ratio (OR) = 0.85, 95% CI 
0.82-0.88; P=7.72x10−20) and rs1642764 at 17p13.1 (per-allele OR= 0.88, 95% CI 0.85-0.91; 
P=3.10x10−13). rs7447927 is a synonymous single nucleotide polymorphism (SNP) in TMEM173 
and rs1642764 is an intronic SNP in ATP1B2, near TP53. Furthermore, a locus in the HLA class 
II region at 6p21.32 (rs35597309) achieved genome-wide significance in the two populations at 
highest risk for ESSC (OR=1.33, 95% CI 1.22-1.46; P=1.99x10−10). Our joint analysis identified 
new ESCC susceptibility loci overall as well as a new locus unique to the ESCC high risk Taihang 
Mountain region.
**Correspondence should be addressed to: Dr. Li-Dong Wang (ldwang@zzu.edu.cn); Dr. Philip Taylor (ptaylor@mail.nih.gov); Dr. 
Dongxin Lin (lindx72@cicams.ac.cn).. 
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Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma are distinct 
diseases with different etiologies. ESCC remains the more common type of esophageal 
carcinoma in economically-developing countries as well as globally. Approximately half of 
the world's 500,000 new ESCC cases annually occur in China where the disease is a major 
public health problem. Three genome wide association studies (GWAS) have examined 
ESCC1-3 and two subsequent analyses used combinations of the three studies4, 5 to report as 
many as 12 loci associated with ESCC risk. Four additional loci have been reported based 
on an interaction with alcohol consumption, a known risk factor for ESCC4. Two of the 
GWAS1, 2 drew subjects primarily from the Taihang Mountain region of Henan and Shanxi 
provinces where ESCC occurs at very high rates. Total mortality due to ESCC and gastric 
cardia cancer can exceed 20% in the highest risk communities in this region6. The third 
GWAS3 drew subjects from a range of locations in China including a substantial collection 
from Beijing, where the population is comprised of people who originate from all provinces. 
The contribution of lifestyle risk factors for ESCC differs widely between locations in 
China, with alcohol consumption being a notable example. Heavy consumption of alcoholic 
beverages is a known cause of ESCC7, but historically was uncommon in the high incidence 
regions of China8. Therefore, alcoholic beverages played little role in the extraordinarily 
high rates, leaving the high incidence largely unexplained. To discover additional novel 
ESCC susceptibility alleles, we conducted a joint analysis of the three original GWAS and 
followed promising signals in an independent set of new cases and controls.
Supplementary Table 1 describes the subjects from the three underlying GWAS, which 
include additional subjects that were scanned after the first round publications plus the 
additional subjects used for replication of the top hits. In our joint analysis we investigated 
for the first time the individual GWAS data drawn from three studies in China, which 
consisted of 5,337 ESCC cases and 5,787 controls of Han Chinese ethnicity. The NCI 
GWAS used the Illumina 660W-Quad SNP microarray, the Henan GWAS used the Illumina 
610-Quad SNP microarray, while the Beijing GWAS used the Affymetrix GeneChip Human 
Mapping 6.0 set. Supplementary Figure 1 shows eigenvector plots from a principal 
components analysis (PCA) of 25,676 uncorrelated genotyped SNPs (r2 < 0.01 in our 
combined control set). The results show distinct clusters corresponding to different source 
populations. However, only the first two eigenvectors were significant in the base cancer 
risk model and were thus used to adjust for population stratification in the final estimates for 
our joint analysis. To explore untyped common variants, we assessed variants based on the 
imputation of 40.5 million variants using version 3 of the 1000 Genomes data as the 
reference for each of the three data sets before combining them as described in the ONLINE 
METHODS and Supplementary Table 2. After filtering out SNPs with MAF < 1% or 
imputation information criteria (INFO) < 0.3, we advanced 7,556,215 SNPs to the 
association analysis. The inflation factor λ for the joint analysis is 1.01 for all SNPs, which 
indicates that population stratification should not be a concern. Supplementary Figure 2 
provides a quantile-quantile plot for the joint case-control comparison with all SNPs and 
after exclusion of SNPs within 500 Kb of loci previously reported to be associated with 
ESCC. Supplementary Figures 3-5 provide individual quantile-quantile plots for each of 
the three underlying GWAS data sets. Fourteen promising SNPs based on the joint analysis 
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(see ONLINE METHODS) were genotyped in an additional 9,654 ESCC cases and 10,058 
controls divided between subjects from Henan Province and Beijing.
The joint analysis identified two new genome-wide significant loci at 5q31.2 (Figure 1a) 
and 17p13.1 (Figure 1b) associated with risk of ESCC in the pooled data of individual 
genotypes of all three GWAS and two replication studies (Table 1 and Supplementary 
Table 3). At 5q31.2, rs7447927, a synonymous SNP located in transmembrane protein 173 
(TMEM173), had a combined per allele odds ratio (OR) and 95% confidence interval (95% 
CI) of 0.85 (0.82-0.88), P=7.72x10−20. At 17p13.1, rs1642764, an intronic SNP located in 
ATPase, Na+/K+ transporting, beta 2 polypeptide (ATP1B2), which is just telomeric to the 
tumor suppressor gene, TP53, had a combined per allele OR (95%CI) of 0.88 (0.85-0.91), 
P=3.10x10−13. No statistically significant heterogeneity was observed across the three 
pooled GWAS and two replication studies for either locus (Table 1). Furthermore, the 
associations were confirmed independently in the follow-up sets collected from both high- 
and low-risk populations.
On further analysis, we observed an additional susceptibility locus that showed geographic 
differences such that the significant association was observed only in the two GWAS1, 2 
which included subjects from populations at the highest risk for ESCC. In joint analyses 
using all three GWAS, a SNP at 6p21.32 showed a nearly genome-wide significant 
association, however, statistically significant heterogeneity among studies (P=0.015) was 
evident when subjects from the Beijing GWAS and replication subjects were included (i.e., 
among the three pooled GWAS and two replication studies as shown in Table 1). The test 
for heterogeneity became non-significant when the Beijing GWAS and Beijing replication 
subjects were excluded (Table 1). Table 1 also shows that when the analyses were restricted 
to subjects from the high incidence regions, rs35597309, located in the HLA Class II gene 
region between HLA-DRB1 and HLA-DQA1, had a per allele OR (95% CI) of 1.33 
(1.22-1.46), P=1.99 x 10-10 (Supplementary Figure 6). This heterogeneity between high- 
and low-risk regions was also evident when data from the three separate GWAS were 
examined (Supplementary Table 4). Further genotyping and possibly sequencing are 
necessary to map the susceptibility alleles across the HLA Class II region due to its complex 
structure defined by long-range haplotypes.
Finally, our joint analysis observed a promising association with rs61271866 (P=5.18 x 
10−8), an intergenic SNP at 9p21.3 that includes the cyclin-dependent kinase inhibitor 2B 
(CDKN2B)-CDKN2A gene cluster (Supplementary Table 3). Variants in this region have 
been associated with risk of melanoma9, childhood acute lymphoblastic leukemia10, chronic 
lymphocytic leukemia11, and glioma12, as well as ESCC13 in a prior study using a subset of 
the samples examined here. This SNP showed heterogeneity among individual studies in the 
GWAS (Supplementary Table 4) and between the joint Stage 1 and replication phase 
results (Supplementary Table 3). The heterogeneity picture for the 9p21.3 locus is more 
varied as compared to the 6p21.32 HLA Class II locus, indicating that validation of this 
finding will require additional work.
For these four SNPs (rs7447927, rs1642764, rs35597309, and rs61271866), we tested for 
interactions by use of alcohol (Supplementary Table 5) or tobacco (Supplementary Table 
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6). Because of the substantial differences in the degree of alcohol and tobacco use by 
population, we did these tests separately for each of the three underlying studies. In total this 
constituted 24 tests and we found one that was nominally significant (rs35597309 and 
tobacco in the NCI GWAS, Supplementary Table 6), but the difference did not replicate in 
the two other studies and thus, is most likely due to chance. We further note that the number 
of GWAS subjects with these covariate data from Henan was limited.
Here we report a new finding of an association between rs7447927, a synonymous SNP in 
TMEM173, and ESCC risk. TMEM173 (also known as STING) facilitates innate immune 
reactions to viruses and bacteria through the production of type 1 interferon14. The only 
previous GWAS hit at this locus (rs13181561) was demonstrated to be associated with the 
modulation of interferon-α responses to the smallpox vaccine15 and is highly correlated 
(r2=0.956 in 1000 Genomes data for CHB population) with rs7447927. rs13181561 is also 
tagged as an expression quantitative trait locus in lymphoblastoid cells (Supplementary 
Table 7) that alters expression of genes in segment AC135457.2. This genomic region 
includes the sodium-dependent vitamin C transporter (SLC23A1), which is critical for 
vitamin C transport16. Interestingly, low vitamin C has been implicated in risk of ESCC17.
The new susceptibility locus at 17p13.1 is marked by rs1642764, an intronic SNP located 
within the ATP1B2 gene; this variant resides in an LD block that includes the 3’ region of 
TP53 (Figure 1b). Alteration of TP53 regulation or function could be a plausible 
explanation for the observed association between rs1642764 and risk of ESCC. It is 
noteworthy that no prior cancer GWAS has reported a conclusive association with a variant 
in or around TP53. Recently, a candidate gene study of genotyped and imputed SNPs across 
TP53 reported a strong association of a SNP with a low minor allele frequency, rs78378222, 
with glioma risk (P=6.86 x 10−24 with a MAF=0.013 in a population of European 
ancestry)18. We also observe that TP53 is frequently inactivated in ESCC19. Our target SNP 
in this region is in LD with several other SNPs, notably rs1050541 (r2=0.575), which alters a 
binding site for RAD21 (Supplementary Table 7). RAD21 is a key component of the 
cohesion complex, which binds to DNA and is essential for mitosis, homologous DNA 
repair, and enhancer activities and may be relevant to cancer20. Alternatively, this SNP falls 
between recombination hotspots that includes the SHBG gene, and variants bracketing this 
SNP are known to be associated with sex hormone binding globulin regulation and serum 
testosterone concentration21. Esophageal cancer is male predominant in low incidence 
populations, but this has typically been attributed to greater tobacco smoking and alcohol 
consumption by men compared to women. Recent studies have suggested that hormonal 
factors may play a role in the development of ESCC22, 23.
In published GWAS, HLA Class II genetic variants in close proximity (<20 kb) of 
rs35597309 on 6p21.32 have been associated with multiple cancers including 
nasopharyngeal carcinoma24, hepatocellular carcinoma25, lung cancer in never smokers26, 
and familial chronic lymphocytic leukemia27 as well as autoimmune diseases, including 
Crohn's disease28 and lupus 29. This SNP resides between HLA-DRB1 and HLADQA1, 
both MHC class 2 genes that function in antigen presentation. The HLA region is large, 
complex, and shows unusually long-range LD that makes the interpretation of GWAS hits in 
this region difficult. rs35597309 is in perfect LD (r2=1.0) with 34 other SNPs within 2 MB 
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(Supplementary Table 7) including two missense mutations in HLADQA1 and a host of 
putative protein binding sites, enhancers, and regulatory motifs. But the LD with top hits in 
this region from previously reported studies of cancer was low; r2<0.1 for rs2860580 
(nasopharyngeal carcinoma), rs9272105 (hepatocellular carcinoma), rs2395185 (lung 
cancer), and rs674313 (chronic lymphocytic leukemia) in 1000 Genomes data for CHB+JPT 
populations.
Our results provide evidence for an association between variants at 6p21.32 and risk of 
ESCC, although the association was restricted to the studies which examined subjects from 
the high incidence Taihang Mountain region. While it is plausible that our results could be 
due to a gene-environment interaction between HLA genotypes and an uncharacterized risk 
factor specific to the Taihang Mountains, it is also possible that chance could account for 
this finding. The result was, however, confirmed in the Henan replication set (P=0.001). We 
know that populations in this region suffer from very high rates of ESCC, which is likely 
multi-factorial and could involve immune challenges. It is also important to note that the 
Han Chinese population is genetically diverse and this difference in association may be due 
to true differences in the genomic structure of the HLA regions between subjects from the 
Taihang Mountains and other parts of China.
But we note that the allele frequency is similar between the Henan and Beijing replication 
sets (Table 1). Future work should use genomic methods specifically designed to investigate 
the HLA region to explore these results. We also note that a region at 6p22.1 that is linked to 
other HLA alleles has been associated with risk of Barrett's esophagus, the precursor lesion 
for esophageal adenocarcinoma30.
Supplementary Table 8 shows the individual GWAS and joint analysis results for the 12 
main effect GWAS loci reported in five previous publications1-5. Joint analysis of the 
pooled data from the three GWAS did not strengthen all previously reported loci. We 
observed strong associations for SNPs in loci harboring PLCE1, CASP8, RUNX1, and 
CHEK2, but no signal for four loci. The Beijing GWAS showed geographic differences in 
associations for some SNPs3 and this variation may be attributed, in part, to differences in 
environmental exposures and habits, such as alcohol consumption. A previous analysis by 
Wu et al. 4 using partial data from two of the studies also showed substantial heterogeneity 
between GWAS. Of 18 hits identified in analyses of both main effects and alcohol 
interactions in the Beijing data, only four replicated in subjects from the Shanxi Upper 
Gastrointestinal Cancer Genetics Study1.
In conclusion, we present the joint analysis of the individual genotype data from three 
previously published GWAS in China and have established two new loci associated with 
risk of ESCC across all three studies, and two promising signals, the most notable, in the 
HLA class II region. The latter appears to be present only in subjects from the high 
incidence Taihang Mountain region of China. Environmental factors have previously been 
shown to be of varied relevance for ESCC in different Chinese populations and this may 
have led to differential GWAS findings. Here we find additional evidence for distinct results 
among these populations. Etiologic heterogeneity may play an important role in interpreting 
GWAS results and should be considered as GWAS are extended to understudied populations 
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with distinct lifestyles. Lastly, further work is needed to fine-map the regions to identify the 
optimal alleles for laboratory studies that will provide an understanding of the basic biology 
underlying the ESCC susceptibility alleles and their interaction with environmental factors.
ONLINE METHODS
Subject selection and genotyping
This study pooled the individual genotype data of subjects from three independent GWAS of 
esophageal squamous cell carcinoma in Han Chinese populations, which were part of three 
earlier reports from the NCI1, Henan2, and Beijing study groups3. The numbers of subjects 
differs in some cases from those listed in the original publications because additional 
subjects were genotyped using the same platform subsequent to the original publications; 
these subjects were included in the joint analysis of the individual genotype data. For the 
NCI GWAS, subjects came from four prospective cohort studies and one large case-control 
study as reported in Abnet et al.1 and all subjects used in replication in the original paper 
were subsequently genotyped using the Illumina 660W-Quad microarray. For the Henan 
scan, subjects were collected from many hospitals in Henan Province and a smaller 
‘genetically-matched’ subset2 (1,076 cases, 713 controls) was selected for this joint analysis. 
Furthermore, 299 cases and 370 controls were added who had subsequently been genotyped 
using the Illumina 610-Quad SNP microarray after the first publication. For the Beijing 
scan, subjects were collected from four different localities as previously reported in Wu et 
al.4 and all subjects were included in the current study. These subjects had been genotyped 
using the Affymetrix GeneChip Human Mapping 6.0 set. Subjects included in the 
replications from both Henan2 and Beijing3 were identified and recruited using the same 
approaches as for subjects included in the GWAS from each of these respective sites and as 
described in the initial publications from each of their GWAS. A description of the included 
subjects is given in Supplementary Table 1.
GWAS data
The details of the analytic pre-processing for the three GWAS were included in each of the 
primary papers. In addition to the quality control procedures performed in the previous 
primary publications for all three studies, SNPs with a call rate < 95% or Hardy-Weinberg 
proportion test P-value < 0.000001 or minor allele frequency < 1% were further removed 
prior to imputation for the current analysis (Supplementary Table 2). We also searched for 
potential duplicates or first degree relatives across all three GWAS with glu ibds module 
(http://code.google.com/p/glu-genetics/) using the set of 25,676 independent SNPs with 
pair-wise r2<0.01 estimated from the GWAS control population. A total of nine pairs of 
duplicates were found; all were between Henan2 and the NIT component of the NCI scan1, 
which enrolled subjects in the same high incidence area of Henan Province. As a result, we 
excluded nine individuals (one from each pair) from the Henan study for the joint analysis. 
Application of standardized QC procedures for subjects and for SNPs resulted in the 
exclusion of an additional small proportion of subjects such that the final numbers of 
subjects in the current analysis are slightly different from those reported previously.
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Imputation analysis
Imputation was conducted separately for each scan using IMPUTE2 software version 2.2.2 
(http://mathgen.stats.ox.ac.uk/impute/impute_v2.html) and version 3 of the 1000 Genomes 
Project data as the reference set. First, the genomic coordinates were lifted over from NCBI 
human genome build 36 to build 37 using the UCSC lift over tool (http://
hgdownload.cse.ucsc.edu/downloads.html). The few loci that failed to be lifted over were 
also excluded from the imputation. Second, the strand of the inference data was aligned with 
the 1000 Genomes data by simple allele state comparison or allele frequency matching for 
A/T and G/C SNPs. We implemented a 4-Mb sliding window to impute across the genome, 
resulting in 744 jobs running in parallel on the NIH BIOWULF cluster (http://
biowulf.nih.gov/). A pre-phasing strategy with SHAPEIT software version 1 (http://
www.shapeit.fr/) was adopted to improve the imputation performance. The phased 
haplotypes from SHAPEIT were fed directly into IMPUTE2. Imputed loci with INFO < 0.3 
or MAF < 0.01 were excluded from further association analysis. To technically validate our 
imputation findings, we optimized TaqMan assays for rs7447927, rs1642764, and 
rs35597309. We genotyped a set of 892 samples from NCI and another set of 752 samples 
from Beijing. For the NCI set, the concordance rates between the imputed genotypes (using 
a posterior probability threshold of 0.95) and TaqMan genotypes were 99.3%, 96.5%, and 
99.1%, respectively and for the Beijing set, the concordance rates between the imputed 
genotypes (using a posterior probability threshold of 0.95) and TaqMan genotypes were 
96.7%, 90.4%, and 99.6%, respectively.
Association analysis
The imputed genotypes were merged using GTOOL software version 0.7.5 (http://
www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html) and the association testing was 
performed using SNPTEST software version 2.2 (https://mathgen.stats.ox.ac.uk/
genetics_software/snptest/snptest.html), with adjustment for age, sex, study, and the top two 
eigenvectors, which controls for population stratification. In the joint analysis baseline 
model (not including SNP effects) adjusting for age, sex, study, and all top ten eigenvectors 
(EVs), the top two eigenvectors were significantly associated with case status (P-value < 
0.05), and were, therefore, included in the final joint analysis association models used to test 
SNP effects across all three studies. In a sensitivity analysis, we also conducted the 
association analyses in each of the three GWAS separately, followed by meta-analyses that 
used the fixed effect inverse variance method to combine the beta estimates and standard 
errors from each scan. In this second approach, we generated the set of eigenvectors based 
on each GWAS and identified significant eigenvectors to control for population stratification 
in each individual GWAS (EV1 for NCI; EV1, EV5 and EV7 for Beijing; no EV was 
needed for Henan). The meta-analysis (Supplementary Table 4) produced very similar 
results to our current joint analysis (Table 1), so we presented results for Stage 1 from the 
joint analysis as our primary analysis. The P for heterogeneity was calculated using 
Cochran's Q, which is distributed as a chi-square statistic with (n-1) degrees of freedom 
where n is the number of sets included in the meta-analysis. For exploring the gene and 
environment interaction with use of alcohol or tobacco, we performed stratified analyses for 
the four novel SNP associations and assessed the risk heterogeneity between drinkers and 
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nondrinkers (Supplementary Table 5), and between smokers and nonsmokers 
(Supplementary Table 6). To evaluate population stratification, we examined QQ plots 
before and after eigenvector adjustment for the joint analysis (Supplementary Figure 7), 
for Beijing (Supplementary Figure 8), and for NCI (Supplementary Figure 9). No figure 
is shown for Henan as no adjustment was required. Further, we examined the association 
with risk for the four novel SNP associations we report here before and after eigenvector 
adjustment (Supplementary Table 9).
Recombination hotspot inference
Likelihood ratio statistics for recombination hotspots were estimated by SequenceLDhot 
software based on background recombination rates inferred by PHASE v2.1 using the 1000 
Genomes CHB data.
Replication genotyping and analysis
After SNPs from previously reported ESCC risk loci were excluded, the top SNPs with p 
values less than 1.0 x 10−5 (n=14) from our Stage 1 analysis were selected for replication 
testing in both Beijing and Henan (Supplementary Table 3). However, when the 
imputation was updated with the addition of more covariate data on subjects, the new Stage 
1 p-value for rs4252725 was only 1.0 x 10−4. At that point, primers for those top 14 SNPs 
from the initial analysis had already been designed and validated, so we proceeded to test all 
14 of these SNPs. Therefore, we reported replication results for all the SNPs that we 
advanced to replication despite the updated analysis of our initial results and the appearance 
of a shift in our criterion. All SNPs genotyped in samples from the additional Beijing 
subjects used optimized TaqMan assays, whereas the Henan replication subjects were 
genotyped using Sequenom (11 SNPs) and TaqMan (three SNPs) assays. Three Sequenom 
assays failed genotyping and one (rs7822239) was repeated using TaqMan because it was 
nominally significant (P = 0.02) in the Beijing replication set. Samples with completion 
rates less than 80% in either replication were excluded from association analysis. 
Association analyses used log additive models with a trend effect and were adjusted for sex 
and age. Replication and Stage 1 results were combined using a fixed effect meta-analysis.
In silico bioinformatics analysis
Using 1000 Genomes CHB data, we identified all SNPs with r2>0.8, 0.8, 0.5 (because no 
SNPs passed the 0.8 threshold), respectively, for the lead SNP in each of the three novel 
regions we identified. We then used HaploReg31 and RegulomeDB32 to explore potential 
functional annotations within the ENCODE data in the genome surrounding our lead SNPs 
(Supplementary Table 7).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Association results, recombination, and linkage disequilibrium plots for the 5q31.2 and 
17p13.1 regions identified in stage 1 (joint analysis of three independent GWAS), for the two 
replications sets (Beijing and Henan), and the joint estimate from all data
(a) 5q31.2:138,701,120–138,885,920 and (b) 17p13.1:7,435,040–7,644,641. Association 
results from a trend test in –log10 Pvalues (y axis, left; gray diamonds, stage I association 
result; sky blue diamonds, Beijing replication result; purple diamonds, Henan replication 
results; red diamonds, joint result) of the SNPs are shown according to their chromosomal 
positions (x axis). Linkage disequilibrium structure based on the 1000 Genomes CHB data 
(n=91) was visualized by snp.plotter software. The line graph shows likelihood ratio 
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statistics (y axis, right) for recombination hotspot by SequenceLDhot software based on the 
background recombination rates inferred by PHASE v2.1 using the 1000 Genomes CHB 
data. Physical locations are based on NCBI human genome build 37. Gene annotation was 
based on the NCBI RefSeq genes from the UCSC Genome Browser.
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